{
    "Trade/Device Name(s)": [
        "GlucoPlus\u2122 Blood Glucose Monitoring System",
        "Glucoplus\u2122 Blood Glucose Test System"
    ],
    "Submitter Information": "GlucoPlus Inc.",
    "510(k) Number": "K061234",
    "Predicate Device Reference 510(k) Number(s)": [
        "K964630"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "October 2, 2006",
    "Summary Letter Received Date": "October 4, 2006",
    "Submission Date": "April 25, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GlucoPlus\u2122 Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Glucose oxidase enzymatic reaction"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for GlucoPlus Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood",
    "Indications for Use Summary": "For quantitative measurement of glucose concentration in capillary whole blood from fingerstick to aid diabetes control; not for diagnosis/screening of diabetes or use in neonates",
    "fda_folder": "Clinical Chemistry"
}